Skip to main content
. 2014 Dec 18;5(1):35–41. doi: 10.1016/j.jtcme.2014.05.001

Table 4.

Effects of AR-A001 and AR-A004 extracts against L1210 lymphoid leukemia in CDF1 mice.

Treatments Dose (mg/kg) Mean survival time (days) % Increase in mean survival time Inference
Normal saline (0.2 mL/mouse) 9
5-FU 20 19 211.11 Significant activity
AR-A001 100 19 211.11 Significant activity
AR-A004 100 14 155.56 Significant activity

5-FU = 5-fluorouracil.

T/C% < 125% = toxic/inactive; T/C% > 125% = significant antileukemic effect.